What is Tong Ren Tang Technologies Co Net Margin %?
Tong Ren Tang Technologies CoTGRNF 50 Net Margin % is 2.10% as of Dec. 2025, which is 78% below its 10-year median of 9.56. GuruFocus rates TGRNF with a GF Score™ of 50/100 and a GF Value™ of $0.84 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 955 Drug Manufacturers companies, Tong Ren Tang Technologies Co ranks better than 51.83% on this metric.
The historical rank and industry rank for Tong Ren Tang Technologies Co's Net Margin % or its related term are showing as below:
TGRNF'
s Net Margin % Range Over the Past 10 Years
Min: 6.09 Med: 9.56 Max: 13.4
Current: 6.09
TGRNF's Net Margin % is ranked better than 51.83% of 955
companies
in the Drug Manufacturers industry
Industry Median: 5.69
vs TGRNF: 6.09
Tong Ren Tang Technologies Co (OTCPK:TGRNF) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Tong Ren Tang Technologies Co Net Margin % Related Terms
Tong Ren Tang Technologies Co Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Tong Ren Tang Technologies Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tong Ren Tang Technologies Co Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Tong Ren Tang Technologies Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Tong Ren Tang Technologies Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tong Ren Tang Technologies Co (TGRNF) has a Net Margin % of 2.10% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Tong Ren Tang Technologies Co and its competitors. This is 78% below median its historical median of 9.56. Over the past decade, Tong Ren Tang Technologies Co's Net Margin % has ranged from 6.09 to 13.40. According to the industry distribution chart, Tong Ren Tang Technologies Co ranks #460 out of 955 companies in the Drug Manufacturers industry, placing it in the top 48.2%.
Is Tong Ren Tang Technologies Co's Net Margin % too high?
Tong Ren Tang Technologies Co's current Net Margin % of 2.10% is 78% below median its 10-year median of 9.56. Over the past 10 years, this metric has ranged from a low of 6.09 to a high of 13.40. The Drug Manufacturers industry median Net Margin % is 5.69. Tong Ren Tang Technologies Co's value of 2.10% is 63.1% below this industry median. Based on the distribution chart, Tong Ren Tang Technologies Co ranks #460 out of 955 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Tong Ren Tang Technologies Co has a GF Score™ of 50/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tong Ren Tang Technologies Co's Net Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Tong Ren Tang Technologies Co ranks #460 out of 955 companies for Net Margin %. This puts Tong Ren Tang Technologies Co in the upper half of its industry. The industry median Net Margin % is 5.69. Tong Ren Tang Technologies Co's value of 2.10% is 63.1% below this benchmark. Historically, Tong Ren Tang Technologies Co's own Net Margin % has ranged from 6.09 to 13.40 over the past decade. While the company's 10-year median is 9.56 vs. the industry median of 5.69, Tong Ren Tang Technologies Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.69, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tong Ren Tang Technologies Co's current Net Margin % of 2.10% is 63.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Tong Ren Tang Technologies Co and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tong Ren Tang Technologies Co's current Net Margin % is 2.10%, which is 78% below median its own 10-year median of 9.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tong Ren Tang Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Tong Ren Tang Technologies Co (TGRNF) is currently considered Significantly Undervalued. The stock's GF Value™ is $0.84, compared to a current price of $0.49 — trading 41.1% below its estimated fair value. The current Net Margin % is 2.10%, which is 78% below median its 10-year median of 9.56 and 63.1% below the Drug Manufacturers industry median of 5.69. Tong Ren Tang Technologies Co's overall GF Score™ is 50/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Tong Ren Tang Technologies Co (TGRNF), the current Net Margin % is 2.10% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tong Ren Tang Technologies Co (TGRNF) Overvalued in 2026?
Based on GuruFocus' analysis, Tong Ren Tang Technologies Co stock appears to be undervalued.
The current stock price of $0.49 is trading 41.1% below its estimated GF Value™ of $0.84.
GuruFocus considers Tong Ren Tang Technologies Co to be Significantly Undervalued.
Key valuation signals for TGRNF:
Net Margin %: 2.10% (78% below median its 10-year median of 9.56)
GF Value™: $0.84 vs. price of $0.49 (41.1% below fair value)
Industry Position: 63.1% below the Drug Manufacturers median (#460 of 955)
No single metric tells the full story. See the TGRNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tong Ren Tang Technologies Co Business Description
Tong Ren Tang Technologies Co Ltd is engaged in the production and distribution of Chinese medicine and predominantly operates in Mainland China and Hong Kong. The operating segments derive their revenue predominantly from the manufacture and sale of Chinese medicine of the company in Mainland China and Tong Ren Tang Chinese Medicine and its subsidiaries engaged in manufacturing, retail, and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments outside Mainland China and wholesale of healthcare products in Mainland China.
50GF Score
Get the complete analysis for TGRNF
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TGRNF has been successfully added to your 
